In A Competitive Landscape, What Gives Xeraya Capital An Edge?
Fares Zahir, CEO, Xeraya Capital
02-Oct-20 08:05
Embed Podcast
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Close
Xeraya Capital is the life sciences investment arm of Khazanah Nasional, invested in medical technology and biological sciences. Why did Khazanah choose to invest in this space? And what edge does Xeraya have? We speak to CEO Fares Zahir about this and more.
Image Credit: Billion Photos / Shutterstock.com
Produced by: Dayana Mustak
Presented by: Khoo Hsu Chuang
This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.
Categories: Health Policy, Diseases and Conditions, Mental Health, Healthy Living, Fitness, Science, Technology, Medical Innovation and Technology, Tech, Business Analysis, Social Issues
Tags: life, sciences, medical technology, Xeraya,
